{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:32:26Z","timestamp":1761291146383,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T00:00:00Z","timestamp":1698537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Protein-driven biological processes play a fundamental role in biomedicine because they are related to pathologies of enormous social impact, such as cancer, neuropathies, and viral diseases, including the one at the origin of the recent COVID-19 pandemic [...]<\/jats:p>","DOI":"10.3390\/biom13111591","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:01:08Z","timestamp":1698555668000},"page":"1591","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protein-Targeting Drug Discovery"],"prefix":"10.3390","volume":"13","author":[{"given":"Caterina","family":"Vicidomini","sequence":"first","affiliation":[{"name":"Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-542X","authenticated-orcid":false,"given":"Giovanni N.","family":"Roviello","sequence":"additional","affiliation":[{"name":"Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/JIR.S282213","article-title":"Understanding COVID-19 pandemic: Molecular mechanisms and potential therapeutic strategies. An evidence-based review","volume":"14","author":"Hanna","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2174\/0929867003374363","article-title":"The GABA transporter and its inhibitors","volume":"7","author":"Soudijn","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.pharmthera.2009.11.007","article-title":"Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs","volume":"125","author":"Madsen","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pharep.2015.04.018","article-title":"The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice","volume":"67","author":"Podkowa","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"O\u2019Hara, J.K., Kerwin, L.J., Cobbold, S.A., Tai, J., Bedell, T.A., Reider, P.J., and Llin\u00e1s, M. (2014). Targeting NAD+ metabolism in the human malaria parasite Plasmodium falciparum. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094061"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Capasso, D., Marino, P., Di Gaetano, S., Borbone, N., Terracciano, M., Trani, R., Longo, C., and Piccialli, V. (2023). Synthesis of Brominated Lactones Related to Mycalin A: Selective Antiproliferative Activity on Metastatic Melanoma Cells and Inhibition of the Cell Migration. Mar. Drugs, 21.","DOI":"10.3390\/md21060349"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Palumbo, R., Simonyan, H., and Roviello, G.N. (2023). Advances in Amino Acid-Based Chemistry. Pharmaceuticals, 16.","DOI":"10.3390\/ph16101490"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1039\/D0DT02572K","article-title":"Tautomeric and conformational switching in a new versatile N-rich heterocyclic ligand","volume":"49","author":"Parisi","year":"2020","journal-title":"Dalton Trans."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2202672","DOI":"10.1002\/adhm.202202672","article-title":"Microfluidic-Assisted Production of Gastro-Resistant Active-Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells","volume":"12","author":"Tramontano","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bothou, C., Sharma, A., Oo, A., Kim, B., Perge, P., Igaz, P., Ronchi, C.L., Shapiro, I., and Hantel, C. (2021). Novel insights into the molecular regulation of ribonucleotide reductase in adrenocortical carcinoma treatment. Cancers, 13.","DOI":"10.3390\/cancers13164200"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/ph4101328","article-title":"Targeting the large subunit of human ribonucleotide reductase for cancer chemotherapy","volume":"4","author":"Wijerathna","year":"2011","journal-title":"Pharmaceuticals"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-biochem-013118-111843","article-title":"Ribonucleotide reductases: Structure, chemistry, and metabolism suggest new therapeutic targets","volume":"89","author":"Greene","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/jacsau.1c00078","article-title":"Iron chelator transmetalative approach to inhibit human ribonucleotide reductase","volume":"1","author":"Gaur","year":"2021","journal-title":"JACS Au"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2767-9764.CRC-23-0268","article-title":"Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress","volume":"3","author":"Croushore","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e10419","DOI":"10.15252\/emmm.201910419","article-title":"Ribonucleotide reductase inhibitors suppress SAMHD 1 ara-CTP ase activity enhancing cytarabine efficacy","volume":"12","author":"Rudd","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Poltronieri, P., Miwa, M., and Masutani, M. (2021). ADP-ribosylation as post-translational modification of proteins: Use of inhibitors in cancer control. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202109.0206.v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E830","DOI":"10.1152\/ajpendo.00150.2020","article-title":"Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity","volume":"318","author":"Horne","year":"2020","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s41061-021-00353-7","article-title":"The repurposed ACE2 inhibitors: SARS-CoV-2 entry blockers of COVID-19","volume":"379","author":"Ahmad","year":"2021","journal-title":"Top. Curr. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Agrawal, P.K., and Blunden, G. (2023). Phytochemicals Against SARS-CoV-2 Infection, SAGE Publications Sage.","DOI":"10.1177\/1934578X231152168"},{"key":"ref_20","first-page":"1934578X221095352","article-title":"Combined network pharmacology, molecular docking, and experimental verification approach to investigate the potential mechanisms of polydatin against COVID-19","volume":"17","author":"Wang","year":"2022","journal-title":"Nat. Prod. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e4668","DOI":"10.1002\/aoc.4668","article-title":"Synthesis, crystal structure, DNA\/bovine serum albumin binding and antitumor activity of two transition metal complexes with 4-acylpyrazolone derivative","volume":"33","author":"Zhang","year":"2019","journal-title":"Appl. Organomet. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10717544.2019.1704945","article-title":"Albumin-based cancer therapeutics for intraperitoneal drug delivery: A review","volume":"27","author":"Cosyns","year":"2020","journal-title":"Drug Deliv."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Greco, F., Falanga, A.P., Terracciano, M., D\u2019Ambrosio, C., Piccialli, G., Oliviero, G., Roviello, G.N., and Borbone, N. (2022). CD, UV, and In Silico Insights on the Effect of 1, 3-Bis (1\u2032-uracilyl)-2-propanone on Serum Albumin Structure. Biomolecules, 12.","DOI":"10.3390\/biom12081071"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Scognamiglio, P.L., Riccardi, C., Palumbo, R., Gale, T.F., Musumeci, D., and Roviello, G.N. (2023). Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems. J. Nanostruct. Chem., 1\u201319.","DOI":"10.1007\/s40097-023-00523-7"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Scognamiglio, P.L., Vicidomini, C., Fontanella, F., De Stefano, C., Palumbo, R., and Roviello, G.N. (2022). Protein Binding of Benzofuran Derivatives: A CD Spectroscopic and In Silico Comparative Study of the Effects of 4-Nitrophenyl Functionalized Benzofurans and Benzodifurans on BSA Protein Structure. Biomolecules, 12.","DOI":"10.3390\/biom12020262"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1016\/j.cub.2020.01.031","article-title":"Tumor-associated macrophages","volume":"30","author":"Cassetta","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liu, H., He, R., Yang, X., Huang, B., and Liu, H. (2023). Mechanism of TCF21 Downregulation Leading to Immunosuppression of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092295"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Shen, C.-K., Huang, B.-R., Charoensaensuk, V., Yang, L.-Y., Tsai, C.-F., Liu, Y.-S., Lu, D.-Y., Yeh, W.-L., and Lin, C. (2023). Bradykinin B1 Receptor Affects Tumor-Associated Macrophage Activity and Glioblastoma Progression. Antioxidants, 12.","DOI":"10.3390\/antiox12081533"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/11\/1591\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:13:41Z","timestamp":1760130821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/11\/1591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,29]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["biom13111591"],"URL":"https:\/\/doi.org\/10.3390\/biom13111591","relation":{},"ISSN":["2218-273X"],"issn-type":[{"type":"electronic","value":"2218-273X"}],"subject":[],"published":{"date-parts":[[2023,10,29]]}}}